Side effects of the LIBTAYO in combination with chemotherapy study in advanced NSCLC

What are the possible side effects of LIBTAYO in combination with chemotherapy?
  • LIBTAYO can cause serious side effects. Click here to review “What is the most Important Safety Information I should know about LIBTAYO?” The most common side effects of LIBTAYO when used alone include: Muscle or bone pain, tiredness, rash and diarrhea
  • The most common side effects of LIBTAYO when used in combination with platinum-containing chemotherapy include:
    • Hair loss
    • Muscle or bone pain
    • Nausea
    • Tiredness
    • Numbness, pain, tingling, or burning in your hands or feet
    • Decreased appetite
  • These are not all the possible side effects of LIBTAYO or LIBTAYO in combination with chemotherapy
  • Call your doctor for medical advice about side effects
In a study, the most common side effects reported in the 312 patients with advanced NSCLC taking LIBTAYO in combination with chemotherapy were:
115 out of 312 patients (37%) experienced hair loss

115 out of 312 patients (37%)
experienced hair loss

94 out of 312 patients (30%) experienced having muscle or bone pain

94 out of 312 patients (30%)
experienced muscle or bone pain

78 out of 312 patients (25%) experienced nausea

78 out of 312 patients (25%)
experienced nausea

72 out of 312 patients (23%) experienced tiredness

72 out of 312 patients (23%)
experienced tiredness

72 out of 312 patients (23%) experienced numbness, pain, tingling, or burning in your hands or feet

72 out of 312 patients (23%)
experienced numbness,
pain, tingling, or burning in
your hands or feet

53 out of 312 patients (17%) experienced decreased appetite

53 out of 312 patients (17%)
experienced decreased appetite

44 out of 312 patients (14%) experienced constipation

44 out of 312 patients (14%)
experienced constipation

41 out of 312 patients (13%) experienced having a rash

41 out of 312 patients (13%)
experienced having a rash

41 out of 312 patients (13%) experienced shortness of breath

41 out of 312 patients (13%)
experienced shortness of breath

37 out of 312 patients (12%) experienced vomiting

37 out of 312 patients (12%)
experienced vomiting

34 out of 312 patients (11%) experienced weight loss

34 out of 312 patients (11%)
experienced weight loss

34 out of 312 patients (11%) experienced trouble falling asleep or staying asleep

34 out of 312 patients (11%)
experienced trouble falling asleep or staying asleep

34 out of 312 patients (11%) experienced diarrhea

34 out of 312 patients (11%)
experienced diarrhea

Review Important Safety Information you should know about LIBTAYO.

Important information
about LIBTAYO